This cluster is too small relative to market cap to have price impact. The CEO's token sale and the CLO/director sales are likely liquidity or tax-planning driven. No bearish signal, ignore for trading decisions.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 26 $119.29entry
- T+1 · 6mo ago +6.84%α +6.83% · $127.45
- T+5 · 6mo ago +9.09%α +7.87% · $130.13
- T+20 · 5mo ago +9.67%α +11.94% · $130.83
- T+60 · 3mo ago +36.16%α +33.70% · $162.43
Price Chart
How similar events traded
Executive Summary
Five Guardant Health insiders, including the CEO and CLO, sold a total of $1.47M in open-market sales over a 7-day window. The cluster is dominated by a director and the CLO, with the CEO's sale being nominal ($20K). The total value is 0.009% of the $15.6B market cap, making it trivial and routine, not indicative of material bearish sentiment.
Key Financial Metrics
Key Facts
- Total open-market sales: $1.47M across 5 insiders (7-day window ending 2026-05-20)
- Largest seller: Director Ian T. Clark ($735K), followed by CLO John G. Saia ($593K)
- CEO AmirAli Talasaz sold only 200 shares ($20K), negligible
- Total sales represent ~0.009% of GH's $15.6B market cap
- Director Manuel Hidalgo Medina exercised options at $0 and $32.55, then sold shares, routine cashless exercise pattern
- No insider purchases in the cluster; net direction is selling
Financial Impact
$1.47M total open-market sales, 0.009% of market cap
Risk Factors
- No material risk from this cluster; insiders retain large positions
- If future clusters show larger dollar amounts or include multiple C-suite executives selling concurrently, that would warrant attention
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-GH-1779483538506 |
Track record
38 reports on GH
3 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +22.49% at T+60 after the May 27, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $145.04 Now $144.03 −0.70% settles Dec 16
- Nov 12, 20264d ago 3 Neutral 1/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $150.87 Now $144.03 −4.53% settles Dec 7
- Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $153.43 Now $144.03 −6.13% settles Dec 4
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $168.58 Now $144.03 −14.56% settles Dec 3
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $175.00 Now $144.03 −17.70% settles Dec 2
- Oct 21, 202626d ago Institutional Cluster Neutral 3/10 Entry $162.94 Now $144.03 −11.61% settles Nov 19
- Oct 14, 20264w ago 144 Neutral 2/10 Entry $165.88 to $154.86 Now $144.03 −13.17% ▼ −6.64% −4.74% vs SPY
- Sep 17, 20268w ago Insider Cluster Bearish 5/10 Entry $179.38 to $158.60 Now $144.03 +19.71% ▲ +11.58% +11.79% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers